gillet01's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.comuser/204372/comments http://seekingalpha.com/article/114633-american-oriental-bioengineering-keeps-growing-despite-bad-moves?source=feed#comment-355489 355489 Second, this will be their new de facto headquarters, they will not officially make it the headquarters since they would lose a large tax benefit were they to move, hence "conference center".




On Jan 14 07:56 AM JSbalaban wrote:

> I wouldn't touch AOB due to their poor business decisions. The only
> thing that saves them is China's still relatively robust economy.
> AOB may have 82M in profit in Q4, but shareholders wont see much
> of that due to AOB's continued diluitive deals. Want a good pharma
> that grows as organically as possible and is a real cash cow for
> their size? Take a look at CSKI. For me, that's the one to own CSKI
> will double before AOB gives you 50%.
>
> JBB]]> Wed, 14 Jan 2009 10:58:10 -0500 Second, this will be their new de facto headquarters, they will not officially make it the headquarters since they would lose a large tax benefit were they to move, hence "conference center".




On Jan 14 07:56 AM JSbalaban wrote:

> I wouldn't touch AOB due to their poor business decisions. The only
> thing that saves them is China's still relatively robust economy.
> AOB may have 82M in profit in Q4, but shareholders wont see much
> of that due to AOB's continued diluitive deals. Want a good pharma
> that grows as organically as possible and is a real cash cow for
> their size? Take a look at CSKI. For me, that's the one to own CSKI
> will double before AOB gives you 50%.
>
> JBB]]> http://seekingalpha.com/article/79620-gsk-s-promatica-gets-thumbs-up-on-nda?source=feed#comment-178119 178119 Mon, 02 Jun 2008 15:29:01 -0400